Vertex Pharmaceuticals Incorpor

Historical 13F Holders

Symbol
VRTX
CUSIP
92532F100
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1,572 238 M $93.2 B
2025 Q2 1,631 242 M $108 B
2025 Q1 1,685 237 M $115 B
2024 Q4 1,644 237 M $95.2 B
2024 Q3 1,631 243 M $112 B
2024 Q2 1,638 245 M $114 B
2024 Q1 1,585 248 M $103 B
2023 Q4 1,528 246 M $99.9 B
2023 Q3 1,359 236 M $82.2 B
2023 Q2 1,349 238 M $83.3 B
2023 Q1 1,266 240 M $75.0 B
2022 Q4 1,290 251 M $72.2 B
2022 Q3 1,197 240 M $69.3 B
2022 Q2 1,164 236 M $66.1 B
2022 Q1 1,131 236 M $61.2 B
2021 Q4 1,100 231 M $50.6 B
2021 Q3 989 231 M $41.8 B
2021 Q2 1,040 233 M $46.9 B
2021 Q1 1,061 237 M $50.7 B
2020 Q4 1,031 241 M $57.3 B
2020 Q3 1,006 243 M $66.1 B
2020 Q2 1,019 244 M $70.9 B
2020 Q1 915 248 M $59.0 B
2019 Q4 875 248 M $54.3 B
2019 Q3 768 248 M $42.1 B
2019 Q2 784 248 M $45.5 B
2019 Q1 793 247 M $45.4 B
2018 Q4 758 247 M $40.9 B
2018 Q3 757 249 M $47.9 B
2018 Q2 743 244 M $41.5 B
2018 Q1 733 243 M $39.5 B
2017 Q4 690 240 M $35.9 B
2017 Q3 660 238 M $36.1 B
2017 Q2 615 236 M $30.4 B
2017 Q1 570 237 M $25.9 B
2016 Q4 525 237 M $17.4 B
2016 Q3 523 241 M $21.0 B
2016 Q2 521 240 M $20.7 B
2016 Q1 526 242 M $18.8 B
2015 Q4 556 237 M $29.9 B
2015 Q3 547 237 M $24.6 B
2015 Q2 530 230 M $28.4 B
2015 Q1 505 234 M $27.6 B
2014 Q4 517 232 M $27.6 B
2014 Q3 478 234 M $26.2 B
2014 Q2 467 232 M $22.0 B
2014 Q1 435 224 M $15.8 B